Laura Navalta

Ms. Navalta has over 30 years of extensive experience in the clinical operations arena and heads Cidara Therapeutics’ clinical trials team. Prior to joining Cidara, she was responsible for leading clinical, regulatory and project management functions, while serving as Chief Operating Officer at C3 Jian Therapeutics and Novalar Pharmaceuticals. Ms. Navalta also served as Executive Director of Clinical Operations at Vical, Inc. and was responsible for all clinical trials in the oncology and infectious disease programs. She has also held management positions at Baxter Healthcare Corporation where she was the Senior Director of Global Clinical Operations, BioScience Division, overseeing the company’s global clinical studies involving coagulation disorders, biosurgery and critical care areas. Ms. Navalta has served in clinical operations senior advisory roles across multiple therapeutic areas and all phases of drug development. Ms. Navalta received her B.A. in Developmental Psychology from the University of Southern California.